Chan, C.T., Moore, J.P., Budzyn, K., Guida, E., Diep, H., Vinh, A., Jones, E.S., Widdop, R.E., Armitage, J.A., Sakkal, S., Ricardo, S.D., Sobey, C.G., Drummond, G.R. (2012). Reversal of vascular macrophage accumulation and hypertension by a CCR2 antagonist in deoxycorticosterone salt-treated mice. Hypertension 60: 1207-12. Budzyn, K., Sobey, C.G. and Drummond, G.R. (2010). Reduced cerebrovascular remodeling and functional impairment in spontaneously hypertensive rats following combined treatment with suboptimal doses of telmisartan and ramipril: is less really more? J Hypertension 28: 1384-1389. Miller, A.A., Budzyn, K. and Sobey, C.G. (2010). Vascular dysfunction in cerebrovascular disease: mechanisms and therapeutic intervention. Clinical Science 119: 1-17. Dikalova, A.E., Bikineyeva, A.T., Budzyn, K., Nazarewicz, R.R., McCann, L., Lewis, W., Harrison, D.G. and Dikalov, S.I. (2010). Therapeutic targeting of mitochondrial superoxide in hypertension. Circ Res 107: 106-116. Nam, D., Ni, C.W., Rezvan, A., Suo, J., Budzyn, K., Llanos, A., Harrison, D.G., Giddens, D., Jo, H. (2010). A model of disturbed flow-induced atherosclerosis in mouse carotid artery by partial ligation and a simple method of RNA isolation from carotid endothelium. J Vis Exp 22 pii: 1861. Nam, D., Ni, C.W., Rezvan, A., Suo, J., Budzyn, K., Llanos, A., Harrison, D.G., Giddens, D., Jo, H. (2009). Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis. Am J Physiol Heart Circ Physiol 297: H1535-43. Budzyn, K., Ravi, R.M., Miller, A.A. and Sobey, C.G. (2008). Mechanisms of augmented vasoconstriction induced by 5-hydroxytryptamine in aortic rings from spontaneously hypertensive rats. British Journal of Pharmacology 155: 210-216. Budzyn, K. and Sobey, C.G. (2007). Vascular rho kinases and their potential therapeutic applications. Current Opinion in Drug Discovery and Development 10: 590-596. Budzyn, K., Paull, M., Marley, P.D. and Sobey, C.G (2006). Segmental differences in the roles of rho-kinase and protein kinase C in mediating vasoconstriction. Journal of Pharmacology and Experimental Therapeutics 317: 791-796. Budzyn, K., Marley, P.D. and Sobey, C.G. (2006). Targeting rho and rho-kinase in the treatment of cardiovascular disease. Trends in Pharmacological Sciences 27: 97-104.